IDRSF
Price
$3.59
Change
-$0.01 (-0.28%)
Updated
Jul 23 closing price
Capitalization
742.13M
NDTP
Price
$0.06
Change
+$0.01 (+20.00%)
Updated
Jul 21 closing price
Capitalization
9.76M
Interact to see
Advertisement

IDRSF vs NDTP

Header iconIDRSF vs NDTP Comparison
Open Charts IDRSF vs NDTPBanner chart's image
Idorsia AG
Price$3.59
Change-$0.01 (-0.28%)
Volume$590
Capitalization742.13M
NDT Pharmaceuticals
Price$0.06
Change+$0.01 (+20.00%)
Volume$12.53K
Capitalization9.76M
IDRSF vs NDTP Comparison Chart in %
Loading...
IDRSF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NDTP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IDRSF vs. NDTP commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IDRSF is a Hold and NDTP is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 27, 2025
Stock price -- (IDRSF: $3.59 vs. NDTP: $0.06)
Brand notoriety: IDRSF and NDTP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IDRSF: 85% vs. NDTP: 353%
Market capitalization -- IDRSF: $742.13M vs. NDTP: $9.76M
IDRSF [@Biotechnology] is valued at $742.13M. NDTP’s [@Biotechnology] market capitalization is $9.76M. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IDRSF’s FA Score shows that 0 FA rating(s) are green whileNDTP’s FA Score has 1 green FA rating(s).

  • IDRSF’s FA Score: 0 green, 5 red.
  • NDTP’s FA Score: 1 green, 4 red.
According to our system of comparison, both IDRSF and NDTP are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IDRSF’s TA Score shows that 4 TA indicator(s) are bullish while NDTP’s TA Score has 2 bullish TA indicator(s).

  • IDRSF’s TA Score: 4 bullish, 3 bearish.
  • NDTP’s TA Score: 2 bullish, 5 bearish.
According to our system of comparison, IDRSF is a better buy in the short-term than NDTP.

Price Growth

IDRSF (@Biotechnology) experienced а +19.67% price change this week, while NDTP (@Biotechnology) price change was +17.31% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.60%. For the same industry, the average monthly price growth was +17.32%, and the average quarterly price growth was +27.29%.

Industries' Descriptions

@Biotechnology (+7.60% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IDRSF($742M) has a higher market cap than NDTP($9.76M). IDRSF YTD gains are higher at: 322.353 vs. NDTP (15.094).
IDRSFNDTPIDRSF / NDTP
Capitalization742M9.76M7,602%
EBITDA-189.01MN/A-
Gain YTD322.35315.0942,136%
P/E Ratio4.54N/A-
Revenue161MN/A-
Total Cash64.8MN/A-
Total Debt1.25BN/A-
FUNDAMENTALS RATINGS
IDRSF vs NDTP: Fundamental Ratings
IDRSF
NDTP
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
81
Overvalued
5
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
3497
P/E GROWTH RATING
1..100
97100
SEASONALITY SCORE
1..100
4285

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NDTP's Valuation (5) in the null industry is significantly better than the same rating for IDRSF (81). This means that NDTP’s stock grew significantly faster than IDRSF’s over the last 12 months.

NDTP's Profit vs Risk Rating (100) in the null industry is in the same range as IDRSF (100). This means that NDTP’s stock grew similarly to IDRSF’s over the last 12 months.

NDTP's SMR Rating (100) in the null industry is in the same range as IDRSF (100). This means that NDTP’s stock grew similarly to IDRSF’s over the last 12 months.

IDRSF's Price Growth Rating (34) in the null industry is somewhat better than the same rating for NDTP (97). This means that IDRSF’s stock grew somewhat faster than NDTP’s over the last 12 months.

IDRSF's P/E Growth Rating (97) in the null industry is in the same range as NDTP (100). This means that IDRSF’s stock grew similarly to NDTP’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IDRSFNDTP
RSI
ODDS (%)
N/A
Bearish Trend 3 days ago
33%
Stochastic
ODDS (%)
Bearish Trend 5 days ago
64%
Bullish Trend 3 days ago
43%
Momentum
ODDS (%)
N/A
Bullish Trend 3 days ago
68%
MACD
ODDS (%)
Bullish Trend 6 days ago
53%
Bearish Trend 3 days ago
49%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
58%
Bullish Trend 3 days ago
64%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
53%
Bearish Trend 3 days ago
46%
Advances
ODDS (%)
Bullish Trend 18 days ago
61%
N/A
Declines
ODDS (%)
Bearish Trend 10 days ago
65%
N/A
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
74%
Bearish Trend 3 days ago
61%
Aroon
ODDS (%)
Bullish Trend 3 days ago
47%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
IDRSF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NDTP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CRPJF2.33N/A
N/A
China Resources Power Holdings Co., Ltd.
JAXAF0.04N/A
N/A
VINYL GROUP LTD.
CRWKF63.99N/A
N/A
Cranswick PLC
BTBIF2.70-0.01
-0.41%
BTB Real Estate Investment Trust
ONXGF1.37-0.11
-7.56%
Onyx Gold Corp

IDRSF and

Correlation & Price change

A.I.dvisor tells us that IDRSF and CADL have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IDRSF and CADL's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IDRSF
1D Price
Change %
IDRSF100%
N/A
CADL - IDRSF
25%
Poorly correlated
+0.29%
NDTP - IDRSF
22%
Poorly correlated
N/A
ANNX - IDRSF
22%
Poorly correlated
-1.57%
HRTX - IDRSF
21%
Poorly correlated
+0.53%
LGVN - IDRSF
21%
Poorly correlated
-1.18%
More

NDTP and

Correlation & Price change

A.I.dvisor tells us that NDTP and CADL have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NDTP and CADL's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NDTP
1D Price
Change %
NDTP100%
N/A
CADL - NDTP
31%
Poorly correlated
+0.29%
IDRSF - NDTP
22%
Poorly correlated
N/A
LIXT - NDTP
22%
Poorly correlated
-4.20%
MMIRF - NDTP
15%
Poorly correlated
N/A
MBXBF - NDTP
7%
Poorly correlated
N/A
More